Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database

High body mass index (BMI) is known to be associated with various conditions, including type 2 diabetes (T2D), osteoarthritis, cardiovascular disease (CVD) and sleep apnoea; however, the impact of intentional weight loss on the risk of these and other outcomes is not well quantified. We examined the...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	International Journal of Obesity Ročník 45; číslo 6; s. 1249 - 1258
Hlavní autoři:	Haase, Christiane Lundegaard, Lopes, Sandra, Olsen, Anne Helene, Satylganova, Altynai, Schnecke, Volker, McEwan, Phil
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Nature Publishing Group 01.06.2021
Témata:	Adult Apnea Asthma Biomedical materials Body mass index Body size Body weight loss Cardiovascular diseases Comorbidity Databases, Factual Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 Dyslipidemia Female Heart diseases Humans Hypertension Kidney diseases Male Middle Aged Obesity Obesity - epidemiology Osteoarthritis Primary Health Care Risk analysis Risk factors Risk management Risk Reduction Behavior Sleep Sleep apnea Sleep disorders Statistical models United Kingdom - epidemiology Weight control Weight loss Weight Loss - physiology United Kingdom United Kingdom > UK
ISSN:	0307-0565, 1476-5497, 1476-5497
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	High body mass index (BMI) is known to be associated with various conditions, including type 2 diabetes (T2D), osteoarthritis, cardiovascular disease (CVD) and sleep apnoea; however, the impact of intentional weight loss on the risk of these and other outcomes is not well quantified. We examined the effect of weight loss on ten selected outcomes in a population from the UK Clinical Practice Research Datalink (CPRD) GOLD database. Included individuals were >18 years old at the index date (first BMI value between January 2001 and December 2010). They were categorised by their weight pattern between year 1 post-index and year 4 post-index (baseline period) as having stable weight (-5% to +5%) or weight loss (-25% to -10%, plus evidence of intervention or dietary advice to confirm intention to lose weight). For inclusion, individuals also required a BMI of 25.0-50.0 kg/m at the start of the follow-up period, during which the occurrence of ten obesity-related outcomes was recorded. Cox proportional hazard models adjusted for BMI, comorbidities, age, sex and smoking status were used to estimate relative risks for weight loss compared with stable weight. Individuals in the weight-loss cohort had median 13% weight loss. Assuming a BMI of 40 kg/m before weight loss, this resulted in risk reductions for T2D (41%), sleep apnoea (40%), hypertension (22%), dyslipidaemia (19%) and asthma (18%). Furthermore, weight loss was associated with additional benefits, with lower risk of T2D, chronic kidney disease, hypertension and dyslipidaemia compared with maintaining the corresponding stable lower BMI throughout the study. This study provides objective, real-world quantification of the effects of weight loss on selected outcomes, with the greatest benefits observed for the established CVD risk factors T2D, hypertension and dyslipidaemia.
AbstractList	High body mass index (BMI) is known to be associated with various conditions, including type 2 diabetes (T2D), osteoarthritis, cardiovascular disease (CVD) and sleep apnoea; however, the impact of intentional weight loss on the risk of these and other outcomes is not well quantified. We examined the effect of weight loss on ten selected outcomes in a population from the UK Clinical Practice Research Datalink (CPRD) GOLD database. Included individuals were >18 years old at the index date (first BMI value between January 2001 and December 2010). They were categorised by their weight pattern between year 1 post-index and year 4 post-index (baseline period) as having stable weight (−5% to +5%) or weight loss (−25% to −10%, plus evidence of intervention or dietary advice to confirm intention to lose weight). For inclusion, individuals also required a BMI of 25.0–50.0 kg/m2 at the start of the follow-up period, during which the occurrence of ten obesity-related outcomes was recorded. Cox proportional hazard models adjusted for BMI, comorbidities, age, sex and smoking status were used to estimate relative risks for weight loss compared with stable weight. Individuals in the weight-loss cohort had median 13% weight loss. Assuming a BMI of 40 kg/m2 before weight loss, this resulted in risk reductions for T2D (41%), sleep apnoea (40%), hypertension (22%), dyslipidaemia (19%) and asthma (18%). Furthermore, weight loss was associated with additional benefits, with lower risk of T2D, chronic kidney disease, hypertension and dyslipidaemia compared with maintaining the corresponding stable lower BMI throughout the study. This study provides objective, real-world quantification of the effects of weight loss on selected outcomes, with the greatest benefits observed for the established CVD risk factors T2D, hypertension and dyslipidaemia. High body mass index (BMI) is known to be associated with various conditions, including type 2 diabetes (T2D), osteoarthritis, cardiovascular disease (CVD) and sleep apnoea; however, the impact of intentional weight loss on the risk of these and other outcomes is not well quantified. We examined the effect of weight loss on ten selected outcomes in a population from the UK Clinical Practice Research Datalink (CPRD) GOLD database. Included individuals were >18 years old at the index date (first BMI value between January 2001 and December 2010). They were categorised by their weight pattern between year 1 post-index and year 4 post-index (baseline period) as having stable weight (-5% to +5%) or weight loss (-25% to -10%, plus evidence of intervention or dietary advice to confirm intention to lose weight). For inclusion, individuals also required a BMI of 25.0-50.0 kg/m2 at the start of the follow-up period, during which the occurrence of ten obesity-related outcomes was recorded. Cox proportional hazard models adjusted for BMI, comorbidities, age, sex and smoking status were used to estimate relative risks for weight loss compared with stable weight. Individuals in the weight-loss cohort had median 13% weight loss. Assuming a BMI of 40 kg/m2 before weight loss, this resulted in risk reductions for T2D (41%), sleep apnoea (40%), hypertension (22%), dyslipidaemia (19%) and asthma (18%). Furthermore, weight loss was associated with additional benefits, with lower risk of T2D, chronic kidney disease, hypertension and dyslipidaemia compared with maintaining the corresponding stable lower BMI throughout the study. This study provides objective, real-world quantification of the effects of weight loss on selected outcomes, with the greatest benefits observed for the established CVD risk factors T2D, hypertension and dyslipidaemia.High body mass index (BMI) is known to be associated with various conditions, including type 2 diabetes (T2D), osteoarthritis, cardiovascular disease (CVD) and sleep apnoea; however, the impact of intentional weight loss on the risk of these and other outcomes is not well quantified. We examined the effect of weight loss on ten selected outcomes in a population from the UK Clinical Practice Research Datalink (CPRD) GOLD database. Included individuals were >18 years old at the index date (first BMI value between January 2001 and December 2010). They were categorised by their weight pattern between year 1 post-index and year 4 post-index (baseline period) as having stable weight (-5% to +5%) or weight loss (-25% to -10%, plus evidence of intervention or dietary advice to confirm intention to lose weight). For inclusion, individuals also required a BMI of 25.0-50.0 kg/m2 at the start of the follow-up period, during which the occurrence of ten obesity-related outcomes was recorded. Cox proportional hazard models adjusted for BMI, comorbidities, age, sex and smoking status were used to estimate relative risks for weight loss compared with stable weight. Individuals in the weight-loss cohort had median 13% weight loss. Assuming a BMI of 40 kg/m2 before weight loss, this resulted in risk reductions for T2D (41%), sleep apnoea (40%), hypertension (22%), dyslipidaemia (19%) and asthma (18%). Furthermore, weight loss was associated with additional benefits, with lower risk of T2D, chronic kidney disease, hypertension and dyslipidaemia compared with maintaining the corresponding stable lower BMI throughout the study. This study provides objective, real-world quantification of the effects of weight loss on selected outcomes, with the greatest benefits observed for the established CVD risk factors T2D, hypertension and dyslipidaemia. High body mass index (BMI) is known to be associated with various conditions, including type 2 diabetes (T2D), osteoarthritis, cardiovascular disease (CVD) and sleep apnoea; however, the impact of intentional weight loss on the risk of these and other outcomes is not well quantified. We examined the effect of weight loss on ten selected outcomes in a population from the UK Clinical Practice Research Datalink (CPRD) GOLD database. Included individuals were >18 years old at the index date (first BMI value between January 2001 and December 2010). They were categorised by their weight pattern between year 1 post-index and year 4 post-index (baseline period) as having stable weight (-5% to +5%) or weight loss (-25% to -10%, plus evidence of intervention or dietary advice to confirm intention to lose weight). For inclusion, individuals also required a BMI of 25.0-50.0 kg/m at the start of the follow-up period, during which the occurrence of ten obesity-related outcomes was recorded. Cox proportional hazard models adjusted for BMI, comorbidities, age, sex and smoking status were used to estimate relative risks for weight loss compared with stable weight. Individuals in the weight-loss cohort had median 13% weight loss. Assuming a BMI of 40 kg/m before weight loss, this resulted in risk reductions for T2D (41%), sleep apnoea (40%), hypertension (22%), dyslipidaemia (19%) and asthma (18%). Furthermore, weight loss was associated with additional benefits, with lower risk of T2D, chronic kidney disease, hypertension and dyslipidaemia compared with maintaining the corresponding stable lower BMI throughout the study. This study provides objective, real-world quantification of the effects of weight loss on selected outcomes, with the greatest benefits observed for the established CVD risk factors T2D, hypertension and dyslipidaemia.
Author	Lopes, Sandra Schnecke, Volker McEwan, Phil Haase, Christiane Lundegaard Olsen, Anne Helene Satylganova, Altynai
Author_xml	– sequence: 1 givenname: Christiane Lundegaard orcidid: 0000-0002-9992-3571 surname: Haase fullname: Haase, Christiane Lundegaard email: ctlh@novonordisk.com organization: Novo Nordisk A/S, Søborg, Denmark. ctlh@novonordisk.com – sequence: 2 givenname: Sandra surname: Lopes fullname: Lopes, Sandra organization: Novo Nordisk A/S, Søborg, Denmark – sequence: 3 givenname: Anne Helene surname: Olsen fullname: Olsen, Anne Helene organization: Novo Nordisk A/S, Søborg, Denmark – sequence: 4 givenname: Altynai surname: Satylganova fullname: Satylganova, Altynai organization: Novo Nordisk A/S, Søborg, Denmark – sequence: 5 givenname: Volker surname: Schnecke fullname: Schnecke, Volker organization: Novo Nordisk A/S, Søborg, Denmark – sequence: 6 givenname: Phil surname: McEwan fullname: McEwan, Phil organization: Health Economics and Outcomes Research (HEOR) Ltd, Cardiff, UK
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33658682$$D View this record in MEDLINE/PubMed
BookMark	eNpd0E9PFTEUBfCGYOQBfgEX5CZu3BRv_0077gwRNZK4gbCcdNo7WJiZPtoZEvz0PsJz4-psfjm59xyzwznPxNh7gecClftUtVBNw1EKjmid4_qAbYS2DTe6tYdsgwotR9OYI3Zc6z0iGoPyLTtSqjGucXLD_txSuvu9wJhrBT9HKKk-QKG4hiXlGfIAuaealmdeaPQLRcjrEvJEFdIMeG5gSuP4QreUtyN9BnpKkeZAMJQ8gYebn7AtafLlGYIvBNEvvveVTtmbwY-V3u3zhN1cfr2--M6vfn37cfHligdj5cIpeBKaFAUTjAtt601wJrRK-tZprzVaE0hFMfTe9MK4KLWXQxOtbS3aQZ2wj6-925IfV6pLN6UaaBz9THmtndyNJYR0wu7oh__ofV7LvLuuk0YpNBpbuVNne7X2E8Vu_133b1X1F6tHe5w
CitedBy_id	crossref_primary_10_12968_jokc_2025_10_2_70 crossref_primary_10_1186_s12985_025_02703_z crossref_primary_10_1016_j_metabol_2024_155937 crossref_primary_10_3390_ijerph182212187 crossref_primary_10_1016_j_clnu_2025_01_016 crossref_primary_10_1089_chi_2022_0158 crossref_primary_10_1186_s12944_025_02432_w crossref_primary_10_1016_j_jff_2023_105848 crossref_primary_10_1097_QMH_0000000000000531 crossref_primary_10_1161_JAHA_122_029282 crossref_primary_10_1177_13591053251313589 crossref_primary_10_1007_s00423_023_02788_6 crossref_primary_10_3390_nu16101510 crossref_primary_10_1186_s10194_021_01337_0 crossref_primary_10_1016_j_jfma_2023_03_013 crossref_primary_10_1016_j_molmet_2023_101801 crossref_primary_10_1038_s41366_024_01467_w crossref_primary_10_1111_dom_15256 crossref_primary_10_1080_14737167_2022_2053676 crossref_primary_10_1016_j_aprim_2024_102953 crossref_primary_10_1007_s13300_024_01615_5 crossref_primary_10_1186_s12913_024_10840_4 crossref_primary_10_1007_s11695_023_06953_0 crossref_primary_10_57264_cer_2024_0044 crossref_primary_10_4093_dmj_2022_0159 crossref_primary_10_1016_j_soard_2024_01_014 crossref_primary_10_1186_s13690_024_01331_3 crossref_primary_10_1038_s41366_024_01664_7 crossref_primary_10_1111_dom_15345 crossref_primary_10_1080_14737167_2021_1908130 crossref_primary_10_1111_dom_14897 crossref_primary_10_1007_s11332_022_00974_5 crossref_primary_10_1038_s41598_023_30434_0 crossref_primary_10_1038_s41598_025_97472_8 crossref_primary_10_1038_s44355_025_00030_2 crossref_primary_10_1108_K_08_2022_1099 crossref_primary_10_1515_fzm_2024_0017 crossref_primary_10_2196_63313 crossref_primary_10_1080_17474124_2023_2264783 crossref_primary_10_1084_jem_20242174 crossref_primary_10_2147_DMSO_S447743 crossref_primary_10_1016_S0140_6736_24_01210_8 crossref_primary_10_1111_dom_70035 crossref_primary_10_1007_s12325_022_02334_8 crossref_primary_10_1038_s41591_025_03922_1 crossref_primary_10_1098_rstb_2024_0160 crossref_primary_10_1007_s12325_022_02415_8 crossref_primary_10_1159_000531032 crossref_primary_10_1016_j_anai_2021_05_027 crossref_primary_10_2147_JEP_S458705 crossref_primary_10_1002_edm2_70086 crossref_primary_10_3390_app15126660 crossref_primary_10_1016_j_bbalip_2023_159292 crossref_primary_10_1002_acr_25022 crossref_primary_10_1002_oby_24232 crossref_primary_10_2196_58916 crossref_primary_10_7759_cureus_24859 crossref_primary_10_3390_nu17152388 crossref_primary_10_1089_pop_2024_0037 crossref_primary_10_1016_j_clnu_2022_06_021 crossref_primary_10_1053_j_jvca_2024_08_006 crossref_primary_10_1001_jamanetworkopen_2023_14741 crossref_primary_10_3389_fnut_2024_1342452 crossref_primary_10_1038_s41366_023_01325_1 crossref_primary_10_1007_s40519_022_01402_w crossref_primary_10_1007_s12325_023_02426_z crossref_primary_10_3390_healthcare10020404 crossref_primary_10_1039_D2FO00555G crossref_primary_10_1093_nutrit_nuaf094 crossref_primary_10_1016_j_chpulm_2025_100156 crossref_primary_10_1111_jhn_70003 crossref_primary_10_3390_nu14020384 crossref_primary_10_1016_j_bjpt_2025_101172 crossref_primary_10_2196_48675 crossref_primary_10_1016_j_jnutbio_2025_109941 crossref_primary_10_3390_nu13103568 crossref_primary_10_1007_s13679_024_00597_6 crossref_primary_10_1038_s41366_023_01398_y crossref_primary_10_2500_aap_2025_46_250041 crossref_primary_10_1007_s12325_025_03194_8 crossref_primary_10_1080_14656566_2022_2104636 crossref_primary_10_1002_edm2_330 crossref_primary_10_1155_2024_8056440 crossref_primary_10_15829_1560_4071_2025_6535 crossref_primary_10_1080_00325481_2023_2172914 crossref_primary_10_1111_imj_15933 crossref_primary_10_1186_s12874_024_02212_7 crossref_primary_10_1111_dom_15785 crossref_primary_10_1007_s12325_024_02932_8 crossref_primary_10_1002_oby_23760 crossref_primary_10_1016_j_eclinm_2024_103049 crossref_primary_10_3390_nu16203505 crossref_primary_10_1080_13557858_2022_2078482 crossref_primary_10_1111_cob_12605 crossref_primary_10_2147_CEOR_S446560 crossref_primary_10_1007_s12325_024_03094_3 crossref_primary_10_3389_fpubh_2025_1477401 crossref_primary_10_1007_s40273_025_01520_0 crossref_primary_10_1016_j_jaip_2023_07_040 crossref_primary_10_1136_bmj_2023_078524 crossref_primary_10_3389_fendo_2023_1249233 crossref_primary_10_1136_bmj_2023_078525 crossref_primary_10_1111_dom_15836 crossref_primary_10_3390_jcm14030812 crossref_primary_10_1016_j_biopha_2023_115127 crossref_primary_10_1016_j_pcd_2021_10_003 crossref_primary_10_1093_eurheartj_ehae178 crossref_primary_10_1007_s11695_024_07475_z crossref_primary_10_1111_acps_13433 crossref_primary_10_12688_f1000research_110211_1 crossref_primary_10_1007_s10880_023_09945_5 crossref_primary_10_1002_kjm2_70077 crossref_primary_10_1097_HEP_0000000000000836 crossref_primary_10_1007_s00125_023_05894_8 crossref_primary_10_1111_dom_15154
ContentType	Journal Article
Copyright	The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml	– notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID	CGR CUY CVF ECM EIF NPM 3V. 7T2 7TK 7TS 7X2 7X7 7XB 88E 88G 8AO 8C1 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ATCPS AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0K M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 7X8
DOI	10.1038/s41366-021-00788-4
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Physical Education Index Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Collection (ProQuest) ProQuest Health & Medical Complete (Alumni) Biological Sciences Agricultural Science Database ProQuest Health & Medical Collection Medical Database Psychology Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China Physical Education Index Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Agricultural & Environmental Science Collection Biological Science Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Agricultural Science Database MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Diet & Clinical Nutrition Recreation & Sports
EISSN	1476-5497
EndPage	1258
ExternalDocumentID	33658682
Genre	Research Support, Non-U.S. Gov't Journal Article
GeographicLocations	United Kingdom United Kingdom--UK
GeographicLocations_xml	– name: United Kingdom – name: United Kingdom--UK
GroupedDBID	--- -Q- ..I .GJ .L3 .XZ 0R~ 1CY 29J 2FS 2WC 36B 39C 4.4 406 53G 5GY 5RE 70F 7X2 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8R4 8R5 A8Z AACDK AAHBH AANZL AASML AATNV AAWTL AAYZH ABAKF ABAWZ ABBRH ABCQX ABDBE ABDBF ABFSG ABIVO ABJNI ABLJU ABOCM ABRTQ ABUWG ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACSTC ACUHS ACZOJ ADBBV ADHUB ADXHL AEFQL AEJRE AEMSY AENEX AEUYN AEVLU AEXYK AEZWR AFBBN AFDZB AFFNX AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AI. AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF APEBS ATCPS ATHPR AXYYD AYFIA AZQEC B0M BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU CGR CS3 CUY CVF DIK DNIVK DPUIP DU5 DWQXO E3Z EAD EAP EBC EBD EBLON EBS ECM EE. EIF EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FERAY FIGPU FIZPM FSGXE FYUFA GNUQQ HCIFZ HMCUK HZ~ IAO IHR IHW INH INR IPY ITC IWAJR JSO JZLTJ KQ8 L7B M0K M1P M2M M7P MVM NPM NQJWS O9- OK1 OVD P2P P6G PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PSYQQ Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UKHRP VH1 WH7 ZGI ZXP ~8M ~KM 3V. 7T2 7TK 7TS 7XB 8FK C1K K9. LK8 PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO
ID	FETCH-LOGICAL-c572t-ecae14e3ec5c58c99a5c85c932a984a44075ce3d1fba5b158d24a2f6d779707f3
IEDL.DBID	M7P
ISICitedReferencesCount	130
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000625063500005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0307-0565 1476-5497
IngestDate	Thu Oct 02 07:11:52 EDT 2025 Mon Oct 06 18:25:36 EDT 2025 Mon Jul 21 04:15:31 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	6
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c572t-ecae14e3ec5c58c99a5c85c932a984a44075ce3d1fba5b158d24a2f6d779707f3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-9992-3571
OpenAccessLink	https://www.nature.com/articles/s41366-021-00788-4.pdf
PMID	33658682
PQID	2533054092
PQPubID	38864
PageCount	10
ParticipantIDs	proquest_miscellaneous_2497112817 proquest_journals_2533054092 pubmed_primary_33658682
PublicationCentury	2000
PublicationDate	2021-06-01
PublicationDateYYYYMMDD	2021-06-01
PublicationDate_xml	– month: 06 year: 2021 text: 2021-06-01 day: 01
PublicationDecade	2020
PublicationPlace	England
PublicationPlace_xml	– name: England – name: London
PublicationTitle	International Journal of Obesity
PublicationTitleAlternate	Int J Obes (Lond)
PublicationYear	2021
Publisher	Nature Publishing Group
Publisher_xml	– name: Nature Publishing Group
SSID	ssj0005502 ssj0033214
Score	2.652396
Snippet	High body mass index (BMI) is known to be associated with various conditions, including type 2 diabetes (T2D), osteoarthritis, cardiovascular disease (CVD) and...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	1249
SubjectTerms	Adult Apnea Asthma Biomedical materials Body mass index Body size Body weight loss Cardiovascular diseases Comorbidity Databases, Factual Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 Dyslipidemia Female Heart diseases Humans Hypertension Kidney diseases Male Middle Aged Obesity Obesity - epidemiology Osteoarthritis Primary Health Care Risk analysis Risk factors Risk management Risk Reduction Behavior Sleep Sleep apnea Sleep disorders Statistical models United Kingdom - epidemiology Weight control Weight loss Weight Loss - physiology
Title	Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database
URI	https://www.ncbi.nlm.nih.gov/pubmed/33658682 https://www.proquest.com/docview/2533054092 https://www.proquest.com/docview/2497112817
Volume	45
WOSCitedRecordID	wos000625063500005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fi9QwEA7enYgv_lg9XT2XEcS3em3aNIkvoucdwrllEQ_3bUmTFBaO9tx2ffCvdybN3j7piy8DpUNJmSQzmfnyDWNvGuucMVYl3qcyKZT3iS6UxoWXihr9Z8lHntmvsqrUcqkXMeHWR1jlbk8MG7XrLOXITznBIDG80PzDzc-EukZRdTW20DhgR8SSwAN0b7GHeIj0lksqp448O1ZE9Poi3qBJc3Xa405eEhYXT9boMlVS_D3eDH7n4uH_jvgRexAjTvg4TpHH7I5vJ2z6ee0HeAuRFvQaqh0r_4Tdm8d6-4RN9lElKoeO6P0T9vtHyKfCNTpYMK0DwqfDhkhgg2bXQDf2G0jCVRnvoNsOOGjfw7qF9J0AanZEqiOA_T342NwU6LoLGLi6hJuRBwMImwYEZCWH-5RdXZx_P_uSxB4OiRWSD4m3xmeFz70VViirtRFWCYtRo9GqMAWeJ4X1ucua2og6E8rxwvCmdFJqmcomP2aHbdf65wxcrXMvVFl6jElK5QwR9eBpC-2ujK7VlJ3s7LCKC7Ff7Y0wZa9vX-MSorqIaX23RZ1Cy4wqinLKno22XsV_XOU5hmil4i_-_fGX7D4P04fSMyfscNhs_St21_4a1v1mxg7kUgapUKqzbMaOPp1Xi2_4NE8vSfL5LMxdlNVi_gdOte7w
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgoALj-XRhQKDBNxCs06c2EgIIUrVah_i0IregmM70kpV0m6yIPhR_EZm8uie4NYD54wsxY-Zb-xv5gN4VVjnjLEq8D5Mg1h5H-hYaTp4ocwpfiai6zM7SxcLdXqqv2zB76EWhmmVg09sHbWrLN-R7wmmQRK80OLD-UXAqlH8ujpIaHTbYup__qCUrX5_tE_r-1qIg8_Hnw6DXlUgsDIVTeCt8ZPYR95KK5XV2kirpCUcY7SKTUwZjrQ-cpMiNzKfSOVEbESRuDTVaZgWEY17Da7HXDLKVEEx31BKZHjZuypiBaChCyOhDNlX7ISR2qspciTM_aVMnkK0CuK_49s2zh3c_d9m6B7c6RE1fuyOwH3Y8uUIxvtL3-Ab7NuenuFiUB0Ywc15zycYwWiDmsm4VXyvH8Cvr-19MZ4RgEBTOmT-Pa64yW1rWRVYdXoKQVsK5B1W64Ymyde4LDF8K5HFnNi0I-i_Q9-LtyKX86DBkymed30-kLl3yERdBhQP4eRK5uoRbJdV6XcAXa4jL1WSeMJciXKGGxFRNkkISxmdqzHsDuue9Y6mzjaLPoaXl5_JRfC7jyl9tSabWKcTfjFNx_C421tZ_49ZFBEETZR48u_BX8Ctw-P5LJsdLaZP4bZoty5fRe3CdrNa-2dww35vlvXqeXsiEL5d9Qb7A_o8RdI
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9QwEB2VLap64WP56EKBQQJuYbNJHNtICAHbFdWW1QpR0VtwbEdaqUrKJguCn8avY5w43RPceuCcUaQ445k39pt5AM8KbYxSWgTWhjxIhLWBTISkjReynPJnGnVzZk_4YiHOzuRyB373vTCOVtnHxDZQm0q7M_Jx5GiQBC9kNC48LWI5nb25-BY4BSl309rLaXQuMrc_f1D5Vr8-ntK_fh5Fs6PP7z8EXmEg0IxHTWC1spPExlYzzYSWUjEtmCZMo6RIVELVDtM2NpMiVyyfMGGiREVFajiXPORFTO-9BrucQEYygN13R4vlpy3BhIWXk6xipwfUz2QkzMF8_04Yi3FNeSR1TGCq6ylhiyD5O9pts97s5v-8Xrfghsfa-LbbHLdhx5ZDGE1XtsEX6AeinuOi1yMYwt5HzzQYwnCLp8m41YKv78CvL-1JMp4TtEBVGnTMfFy78betZVVg1SktBG2TkDVYbRpaMFvjqsTwJUMn8-RMO-r-K7Re1hVdow8qPJ3jRTcBBB0rDx2F10GNu3B6JWt1DwZlVdoDQJPL2DKRppbQWCqMciOKqM4k7CWUzMUIDnsfyHwIqrOtA4zg6eVjCh7uRkiVttqQTSL5xN2l8hHc7_ws89-YxTGB01RED_798iewR36VnRwv5g9hP2q92J1RHcKgWW_sI7iuvzerev3Ybw-Er1ftYX8AaNdP7A
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Weight+loss+and+risk+reduction+of+obesity-related+outcomes+in+0.5+million+people%3A+evidence+from+a+UK+primary+care+database&rft.jtitle=International+Journal+of+Obesity&rft.au=Haase%2C+Christiane+Lundegaard&rft.au=Lopes%2C+Sandra&rft.au=Olsen%2C+Anne+Helene&rft.au=Altynai%2C+Satylganova&rft.date=2021-06-01&rft.pub=Nature+Publishing+Group&rft.issn=0307-0565&rft.eissn=1476-5497&rft.volume=45&rft.issue=6&rft.spage=1249&rft.epage=1258&rft_id=info:doi/10.1038%2Fs41366-021-00788-4&rft.externalDBID=HAS_PDF_LINK
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0307-0565&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0307-0565&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0307-0565&client=summon